Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2006 051 728.9 |
96 | EP file number | EAKZ | 06 75 2979.2 |
86 | WO file number | WAKZ | PCT/CN2006/001370 |
97 | EP publication number | EPN | 1897867 |
87 | WO publication number | WPN | 2006133652 |
54 | Designation/title | TI | VERBINDUNGEN ZUR UNTERBRECHUNG DER WIEDERAUFNAHME VON 5-HYDROXYTRYPTAMIN UND NOREPINEPHRIN ODER ZUR BEHANDLUNG VON KRANKHEITEN WIE DEPRESSION |
51 | IPC main class | ICM (ICMV) | C07C 271/44 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | C07C 219/28 (2006.01), A61K 31/222 (2006.01), A61P 25/00 (2006.01) |
22 | DE application date | DAT | Jun 16, 2006 |
96 | EP application date | EAT | Jun 16, 2006 |
86 | WO application date | WAT | Jun 16, 2006 |
43 | Date of first publication | OT | Dec 21, 2006 |
| Date of publication of grant | PET | Feb 15, 2017 |
71/73 | Applicant/owner | INH | Li, Youxin, Zhuzhou, Hunan, CN; Shandong Luye Pharmaceutical Co., Ltd., Shangdong Province, CN |
72 | Inventor | IN | ZANG, Luping, Tianyuan District, Zhuzhou, Hunan 412000, CN |
| Address for service | | RWS Group, Translation Division, CHALFONT ST PETER, Bucks SL9 9FG, GB |
33 31 32
| Foreign priority | PRC PRNA PRDA
| CN 200610073308 Apr 7, 2006
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| CN 200510077510 Jun 17, 2005
|
| Due date | FT FG | Jun 30, 2025 Annual fee for the 20th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000001897867 Searchable text:
EP000001897867 Original document:
EP000001897867B1 Searchable text:
EP000001897867B1 Original document:
WO002006133652 Searchable text:
WO002006133652 |
43 | Date of first publication | EVT | Dec 21, 2006 |
| Date of the first transfer into DPMAregister | EREGT | May 27, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | Feb 8, 2025 (Show all update days)(Hide all update days)- Feb 8, 2025
- St.36: changed (technical change)
- Jun 21, 2024; Jun 22, 2023; Jun 16, 2022; Jun 24, 2021; Jun 18, 2020; Aug 21, 2019; Jun 25, 2019; Oct 25, 2018; Jun 21, 2018; Feb 22, 2018; Jan 18, 2018; Aug 1, 2017; Jul 27, 2017; Jul 5, 2017; Jul 4, 2017; Jun 13, 2017; Jun 3, 2017; Mar 2, 2017; Feb 16, 2017; Jun 30, 2016; Feb 1, 2013; Oct 6, 2011
- Historical data not available for this/these date(s)
- May 27, 2011
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 9)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Jul 4, 2017 |
| Issue number | HN | 32 |
| Year | PJ | 2017 |
| Publication date | VT | Aug 10, 2017 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Li, Youxin, Zhuzhou, Hunan, CN; Shandong Luye Pharmaceutical Co., Ltd., Shangdong Province, CN |
71/73 | Previous applicant/owner | INHF | Li, Youxin, Zhuzhou, Hunan, CN, Shandong Luye Pharmaceutical Co., Ltd., Yantai City, Shandong, CN |